Halsey Associates Inc. CT raised its stake in shares of Core Laboratories (NYSE:CLB) by 4.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 62,640 shares of the oil and gas company’s stock after buying an additional 2,395 shares during the quarter. Halsey Associates Inc. CT owned about 0.14% of Core Laboratories worth $6,862,000 at the end of the most recent reporting period.
A number of other large investors also recently made changes to their positions in CLB. Janus Henderson Group PLC boosted its holdings in shares of Core Laboratories by 105.2% during the third quarter. Janus Henderson Group PLC now owns 10,264 shares of the oil and gas company’s stock worth $1,013,000 after purchasing an additional 5,262 shares during the last quarter. California State Teachers Retirement System acquired a new stake in shares of Core Laboratories during the second quarter worth $1,131,000. Bank of New York Mellon Corp boosted its holdings in shares of Core Laboratories by 141.7% during the third quarter. Bank of New York Mellon Corp now owns 567,306 shares of the oil and gas company’s stock worth $55,992,000 after purchasing an additional 332,620 shares during the last quarter. Jackson Square Partners LLC boosted its holdings in shares of Core Laboratories by 3.5% during the third quarter. Jackson Square Partners LLC now owns 461,558 shares of the oil and gas company’s stock worth $45,555,000 after purchasing an additional 15,404 shares during the last quarter. Finally, Janney Montgomery Scott LLC boosted its holdings in shares of Core Laboratories by 75.7% during the third quarter. Janney Montgomery Scott LLC now owns 20,520 shares of the oil and gas company’s stock worth $2,025,000 after purchasing an additional 8,844 shares during the last quarter.
Core Laboratories (NYSE CLB) traded up $0.87 during trading hours on Tuesday, reaching $105.94. The company’s stock had a trading volume of 27,729 shares, compared to its average volume of 461,410. The company has a quick ratio of 1.66, a current ratio of 1.98 and a debt-to-equity ratio of 1.53. Core Laboratories has a one year low of $86.55 and a one year high of $121.39. The stock has a market capitalization of $4,713.66, a price-to-earnings ratio of 53.37 and a beta of 1.47.
Core Laboratories (NYSE:CLB) last released its quarterly earnings data on Wednesday, January 31st. The oil and gas company reported $0.58 EPS for the quarter, meeting the consensus estimate of $0.58. Core Laboratories had a return on equity of 58.25% and a net margin of 12.60%. The company had revenue of $172.00 million for the quarter, compared to analyst estimates of $171.92 million. During the same period last year, the company posted $0.41 earnings per share. The firm’s revenue was up 15.1% compared to the same quarter last year. research analysts predict that Core Laboratories will post 2.7 EPS for the current fiscal year.
Several equities research analysts have recently issued reports on CLB shares. Zacks Investment Research cut Core Laboratories from a “hold” rating to a “sell” rating in a report on Monday, February 5th. Royal Bank of Canada set a $110.00 target price on Core Laboratories and gave the company a “buy” rating in a report on Thursday, December 21st. ValuEngine cut Core Laboratories from a “hold” rating to a “sell” rating in a report on Thursday, March 1st. Loop Capital set a $115.00 target price on Core Laboratories and gave the company a “buy” rating in a report on Thursday, December 7th. Finally, Deutsche Bank cut Core Laboratories from a “buy” rating to a “hold” rating and reduced their target price for the company from $116.30 to $109.00 in a report on Thursday, January 11th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and four have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $111.39.
Core Laboratories Company Profile
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.
Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories (NYSE:CLB).
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.